| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section of Comparative Medicine (G.-Q.Y.), Department of Internal Medicine (J.-J.W., B.-H.S., M.A.M., K.I.), and Department of Orthopedics (N.T.), Yale University School of Medicine, New Haven, Connecticut 06520-8016
Address all correspondence and requests for reprints to: Dr. Gang-Qing Yao, Section of Comparative Medicine, Yale University School of Medicine, P.O. Box 208016, New Haven, Connecticut 06520-8016. E-mail: gang-qing.yao{at}yale.edu.
The specific biological function of the cell surface or membrane-bound isoform of colony-stimulating factor-1 (mCSF-1) is not well understood. To help define the role of this isoform in bone, we developed a transgenic mouse in which targeted expression of human mCSF-1 in osteoblasts was achieved under the control of the 2.4-kb rat collagen type I 
promoter. Bone density, determined by peripheral quantitative computed tomography, was reduced 7% in mCSF-1 transgenic compared with that in wild-type mice. Histomorphometric analyses indicated that the number of osteoclasts in bone (NOc/BPm, NOc/TAR, OcS/BS) was significantly increased in transgenic mice (1.7- to 1.8-fold; P < 0.05 to P < 0.01) compared with that in wild-type animals. Interestingly, the osteoblast-restricted isoform transgene corrected the osteopetrosis seen in CSF-1-deficient op/op mice. Skeletal growth and bone density in op/op mice expressing mCSF-1 in osteoblasts were similar to those in wild-type mice and were dramatically different from those in the unmanipulated op/op animals. The op/op mice expressing mCSF-1 in bone had normal incisor and molar tooth eruption, whereas the op/op mice evidenced the expected failure of tooth eruption. These findings directly support the conclusion that mCSF-1 is functionally active in bone in vivo and is probably an important local source of CSF-1.
This article has been cited by other articles:
 |
|
 |
|
  K. Horiuchi, T. Miyamoto, H. Takaishi, A. Hakozaki, N. Kosaki, Y. Miyauchi, M. Furukawa, J. Takito, H. Kaneko, K. Matsuzaki, et al. Cell Surface Colony-Stimulating Factor 1 Can Be Cleaved by TNF-{alpha} Converting Enzyme or Endocytosed in a Clathrin-Dependent Manner J. Immunol., November 15, 2007; 179(10): 6715 - 6724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ovadia, K. Insogna, and G.-Q. Yao The Cell-Surface Isoform of Colony Stimulating Factor 1 (CSF1) Restores but Does Not Completely Normalize Fecundity in CSF1-Deficient Mice Biol Reprod, February 1, 2006; 74(2): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M. Mitrasinovic, A. Grattan, C. C. Robinson, N. B. Lapustea, C. Poon, H. Ryan, C. Phong, and G. M. Murphy Jr Microglia Overexpressing the Macrophage Colony-Stimulating Factor Receptor Are Neuroprotective in a Microglial-Hippocampal Organotypic Coculture System J. Neurosci., April 27, 2005; 25(17): 4442 - 4451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Knopp, N. Troiano, M. Bouxsein, B.-h. Sun, K. Lostritto, C. Gundberg, J. Dziura, and K. Insogna The Effect of Aging on the Skeletal Response to Intermittent Treatment with Parathyroid Hormone Endocrinology, April 1, 2005; 146(4): 1983 - 1990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-M. Dai, X.-H. Zong, V. Sylvestre, and E. R. Stanley Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1 Blood, February 1, 2004; 103(3): 1114 - 1123. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
